API
< Back to all clusters
[HEALTH] · France, United States · 3 sources

started · updated

Sepsis diagnosis advances through rapid testing and AI technology

Sepsis remains a critical global health challenge, contributing to hundreds of thousands of deaths annually in both France and the United States. Recent developments highlight the growing importance of rapid microbiological diagnostics and artificial intelligence in improving patient outcomes.

In France, new clinical guidelines from the Haute Autorité de santé and the international Surviving Sepsis Campaign have recognized the value of rapid microbiological tests. These tools help clinicians identify pathogens more quickly, allowing for earlier adjustments to antibiotic therapy and supporting antibiotic stewardship.

In the United States, research indicates that AI-based machine learning alerts can predict sepsis onset significantly earlier than traditional screening methods like SIRS or qSOFA. Some models have demonstrated the ability to predict sepsis up to six hours before onset using continuous vital sign data. The effectiveness of these AI alerts relies heavily on integration into clinical workflows and the active role of nurses in bedside assessment and rapid response.

Entities

Haute Autorité de Santé · Surviving Sepsis Campaign · bioMérieux